Marc O. Williams

We advised Disruptive Acquisition Corporation I, a SPAC, on its IPO and Nasdaq listing

Davis Polk advised Freeport-McMoRan Inc. in connection with its $550 million sale of its interests in the Kisanfu project to a wholly owned subsidiary of China Molybdenum Co., Ltd. The…

We are advising VF on its acquisition

Davis Polk is advising Morgan Stanley on its $7 billion acquisition of Eaton Vance Corp. The acquisition is subject to customary closing conditions and is expected to close in the second…

Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion,…

Davis Polk is advising Emerson Electric Co. on its $1.6 billion acquisition of Open Systems International, Inc. Emerson, headquartered in St. Louis, Missouri, is a global technology and…

Davis Polk is advising Morgan Stanley on its $13 billion acquisition of E*TRADE Financial Corporation. The transaction is expected to close in the fourth quarter of 2020, subject to…

Davis Polk advised Banco Santander, S.A. on its concurrent exchange offers in the United States and Mexico to acquire all of the equity of Banco Santander México, S.A., Institución de Banca…

Davis Polk is advising Freeport-McMoRan Inc. (“FCX”) on its agreement to sell its cobalt refinery in Kokkola, Finland and related cobalt cathode precursor business to Umicore for total…

Davis Polk advised V.F. Corporation in connection with the spinoff of its wholly owned subsidiary, Kontoor Brands, Inc., into an independent, publicly traded company through a tax-free…